Bone Growth Stimulator Market

7500+ companies worldwide approach us every year for their revenue growth initiatives
Global top 2000 strategist rely on us for their growth strategies.
80% of fortune 2000 companies rely on our research to identify new revenue sources.
30000 High Growth Opportunities
95% renewal rate
KNOW MORE
  1. HOME
  2. Top Market Reports
  3. Bone Growth Stimulator Market

Bone Growth Stimulator Market by Product (Device (External Bone Growth Stimulators), Platelet-Rich Plasma), Application (Spinal Fusion Surgeries, Oral & Maxillofacial Surgeries), End Users (Hospital, Ambulatory surgical centers) - Global Forecast to 2027

FREE BROCHURE FREE SAMPLE REPORT
Report Code: MD 5234 Oct, 2022, by marketsandmarkets.com

The bone growth stimulators market size is projected to reach USD 1.8 billion by 2027, at a CAGR of 5.9% from 2022 to 2027. The growing demand for bone growth stimulators in spinal fusion surgeries, delayed union and nonunion bone fractures applications and the increasing demand for bone growth stimulator devices are the major driving factors of this market.

Growth Opportunities in Bone Growth Stimulators Market

Bone Growth Stimulator Market

e-estimated, p-projected

To know about the assumptions considered for the study, Request for Free Sample Report

Bone Growth Stimulators Market Size, Share, Trends and Dynamics

Drivers: Growing patient preference for non-invasive and minimally invasive surgical treatments

The rising incidence of age-related disorders (such as rheumatoid arthritis, osteoarthritis, osteoporosis and fractures) and sports injuries drive the demand of non-invasive and minimally invasive surgical treatments worldwide.

Minimally invasive therapeutic procedures are increasingly being preferred owing to their benefits, such as painless treatment, reduced postoperative hospital stay, reduced surgical trauma, limited tissue scarring, reduced surgical risks, improved patient care, shorter postoperative recovery periods, and greater affordability. These procedures are used for a broad range of spinal disorders, such as spondylosis/spondylolisthesis, stenosis, pseudarthrosis, fractures, trauma, and bone healing.

Restraint: Limited medical reimbursement for bone stimulation products

The healthcare system is facing a number of challenges owing to the rising healthcare costs and rising geriatric population (coupled with the growth in the prevalence of age-related disorders). Medical reimbursement is among the major factors that affect the adoption and demand of specific diagnostic or therapeutic products among patients and healthcare providers at the country level. many private insurance providers do not include insurance or reimbursement for bone growth stimulation surgeries. For instance, most healthcare insurance providers worldwide (except in the US) do not cover the cost of plasma therapy owing to a lack of sufficient clinical data related to its therapeutic efficacy. This factor may act as a restraint in the bone growth stimulators market.

Opportunity: Increasing use of PRP in other applications

Platelet-rich plasma (PRP) is increasingly being used in various therapeutic areas as the first-line therapy for various orthopedic conditions, such as musculoskeletal injuries, arthritis, and chronic tendinitis. This can primarily be attributed to the effective tissue growth capabilities and the advantages offered by PRP (such as no or fewer immunogenic reactions or disease transfer as it is prepared from autologous blood). PRP-based therapy is noninvasive, clinically safer, and helps in faster patient recovery as compared to conventional surgical therapies. For instance, PRP therapy is widely preferred during hair transplantation and plastic surgeries. PRP is also effective in the treatment of cardiac muscle injuries and nerve injuries, and its use is increasing in periodontal surgeries and wound healing. The clinical applications of PRP are expected to increase across major healthcare markets in the coming years, mainly due to the minimal clinical risks associated with its use. This, in turn, is expected to offer significant growth opportunities to players offering PRP products in the market.

Challenge: Side effects associated with BMP-based orthopedic treatment

Although BMPs are increasingly being used in spinal fusion and bone healing, they are associated with certain side effects. Tissue swelling, male infertility, and implant dislodgement are the major side effects associated with BMPs during spinal fusion surgery. During bone healing, BMPs are reported to cause antigenic reactions and stimulation of oncogenes. Medtronic reported several clinical complications associated with its BMP product during its use in spinal fusion surgeries for bone healing. Patients treated with high doses of rhBMP are at a higher risk of cancer as compared to patients treated with other alternatives. rhBMP-based spinal surgeries are associated with 10–50% higher risks of adverse effects as compared to conventional spinal surgeries. Adverse reactions and clinical risks associated with BMP-based therapies during orthopedic treatment are expected to restrict their demand, thereby hindering market growth.

Bone Growth Stimulators Market Ecosystem

Bone Growth Stimulator Market Ecosystem

By Product

In 2021, spinal fusion surgeries segment accounted for the largest share of the bone growth stimulator market, by product

By product type, the global bone growth stimulators market is segmented into bone growth stimulation devices, bone morphogenetic proteins (BMPs), and platelet-rich plasma (PRP). In 2021, the bone growth stimulation devices segment accounted for the largest share of the global bone growth stimulators market. The growing prevalence of nonunion fractures and increasing preference for non-surgical treatment procedures, will boost the market growth.

By Application

In 2021, Spinal fusion surgeries dominated bone growth stimulators market

On the basis of application, the global bone growth stimulators market is broadly segmented into spinal fusion surgeries, delayed union and nonunion bone fractures, oral and maxillofacial surgeries, and other applications. The spinal fusion surgeries segment accounted for the largest share of the global bone growth stimulators market in 2021. The market growth can be attributed to growing demand of spinal fusion surgeries.

By Region

In 2021, North America accounted for the largest share of the bone growth stimulators market

The global bone growth stimulators market is segmented into four major regions namely, North America, Europe, the Asia Pacific, Latin America and Middle East & Africa. North America accounted for the largest share of the bone growth stimulators market in 2021. Factors such as the growing demand for minimally invasive orthopedic therapies is contributing to the large share of this regional segment.

Bone Growth Stimulator Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Bone Growth Stimulators Market - Key Players

The bone growth stimulators market is dominated by players such as Orthofix Medical Inc. (US), Enovis Corporation (Formerly Colfax (US), ZimVie (US), Bioventus LLC (US) and Medtronic plc (Ireland).

Scope of the Bone Growth Stimulator Market Report

Report Attributes

Details

Market size value in 2022:

USD 1.4 billion by 2022

Projected to reach by 2027:

USD 1.8 billion by 2027

CAGR:

5.9%

Base Year Considered:

2021

Forecast Period:

2022-2027

Largest Market:

North America

Region Covered:

North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA)

Segments Covered:

By Product, Application, and Region

Companies Covered:

Orthofix Medical Inc. (US), Enovis (US), ZimVie (US), Bioventus LLC (US), Medtronic plc (Ireland), Stryker (US), DePuy Synthes (US), Arthrex, Inc. (US), Isto Biologics (US Terumo Corporation (Japan), Ember Therapeutics, Inc. (US), Ossatec Benelux Ltd. (Netherlands), Altis Biologics (Pty) Ltd. (South Africa), Regen Lab SA (Switzerland), ITO Co., Ltd. (Japan), Elizur Corporation (US), BTT Health GmbH (Germany), Stimulate Health (Canada), VQ OrthoCare (US), and Kinex Medical Company, LLC (US), Dr. PRP USA LLC (US), Fintek Bio-Electric Inc., Exactech, Inc., and IGEA S.p.A. (Italy). Major 25 players covered.

This research report categorizes the bone growth stimulators market based on product, application, end user and region.

Bone Growth Stimulators Market, by Material Type

  • Bone Growth Stimulation Devices
    •  External Bone Growth Stimulators
      • Ultrasonic Bone Growth Stimulators
      • Implanted Bone Growth Stimulators
  • Bone Morphogenetic Proteins
  • Platelet-Rich Plasma

Bone Growth Stimulators Market, by Application

  • Spinal Fusion Surgeries
  • Delayed Union & Nonunion Bone Fractures
  • Oral & Maxillofacial Surgeries
  • Other Applications

Bone Growth Stimulators Market, by End User

  • Hospitals and Ambulatory Surgical Centers
  • Home Care Settings
  • Academic and Research Institutes

Bone Growth Stimulators Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • RoE
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
    • RoLA
  • Middle East & Africa

Recent Developments

  • In 2022, Orthofix Medical Inc. (US) received FDA premarket approval for the AccelStim Bone Growth Stimulation Device.
  • In 2021, The company announced the competition of its spinoff of ZimVie. The spinoff marks a major milestone in the active portfolio management of Zimmer Biomet.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 29)
    1.1 STUDY OBJECTIVES
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 STUDY SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 GEOGRAPHIC SCOPE
           1.3.3 YEARS CONSIDERED
    1.4 CURRENCY CONSIDERED
    1.5 LIMITATIONS
    1.6 MARKET STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 33)
    2.1 RESEARCH DATA
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 2 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 4 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION
          FIGURE 5 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
           2.2.1 GROWTH FORECAST
                    FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
                    FIGURE 7 TOP-DOWN APPROACH
    2.3 DATA TRIANGULATION
          FIGURE 8 DATA TRIANGULATION
    2.4 RESEARCH ASSUMPTIONS
          FIGURE 9 ASSUMPTIONS FOR STUDY
          TABLE 1 INDICATORS AND ASSUMPTIONS
    2.5 RISK ASSESSMENT

3 EXECUTIVE SUMMARY (Page No. - 45)
    FIGURE 10 BONE GROWTH STIMULATORS MARKET, BY PRODUCT,  2022 VS. 2027 (USD MILLION)
    FIGURE 11 BONE GROWTH STIMULATORS MARKET, BY APPLICATION,  2022 VS. 2027 (USD MILLION)
    FIGURE 12 BONE GROWTH STIMULATORS MARKET, BY END USER,  2022 VS. 2027 (USD MILLION)
    FIGURE 13 GEOGRAPHICAL SNAPSHOT OF BONE GROWTH STIMULATORS MARKET

4 PREMIUM INSIGHTS (Page No. - 48)
    4.1 BONE GROWTH STIMULATORS MARKET OVERVIEW
          FIGURE 14 RISING PREVALENCE OF ORTHOPEDIC DISORDERS TO DRIVE MARKET
    4.2 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET,  BY PRODUCT AND COUNTRY (2022)
          FIGURE 15 BONE GROWTH STIMULATION DEVICES TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022
    4.3 GEOGRAPHIC SNAPSHOT OF BONE GROWTH STIMULATORS MARKET
          FIGURE 16 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 51)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
          FIGURE 17 BONE GROWTH STIMULATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 MARKET DRIVERS
                    5.2.1.1 Growing patient preference for noninvasive and minimally invasive surgical treatments
                    5.2.1.2 Increasing target patient population
                    5.2.1.3 Rising number of sports and accident-related orthopedic injuries
                                FIGURE 18 US: INJURIES CAUSED BY VARIOUS SPORTS ACTIVITIES (2021)
                    5.2.1.4 Rising geriatric population
                                TABLE 2 GERIATRIC POPULATION, BY REGION, 2022 VS. 2030 VS. 2050
           5.2.2 MARKET RESTRAINTS
                    5.2.2.1 Limited medical reimbursement for bone stimulation products
                    5.2.2.2 High treatment costs associated with BMP and PRP products
                    5.2.2.3 Limited clinical evidence to support therapeutic efficacy of bone growth stimulators
           5.2.3 MARKET OPPORTUNITIES
                    5.2.3.1 Emerging markets
                    5.2.3.2 Increasing use of PRP in other applications
                    5.2.3.3 Rising number of hospitals and surgical centers
                                TABLE 3 NUMBER OF ASCS AND OPERATING ROOMS, 2015–2020
           5.2.4 MARKET CHALLENGES
                    5.2.4.1 Lack of access to diagnostics
                    5.2.4.2 Side effects associated with BMP-based orthopedic treatment
                                TABLE 4 CLINICAL SIDE EFFECTS ASSOCIATED WITH BMP-2
                                TABLE 5 PRECLINICAL SIDE EFFECTS WITH BMP-2 (IN VITRO AND IN VIVO)
    5.3 PRICING ANALYSIS
          TABLE 6 PRICE RANGE FOR BONE GROWTH STIMULATORS
    5.4 VALUE CHAIN ANALYSIS
          FIGURE 19 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
    5.5 SUPPLY CHAIN ANALYSIS
           5.5.1 PROMINENT COMPANIES
           5.5.2 SMALL & MEDIUM-SIZED ENTERPRISES
           5.5.3 END USERS
                    FIGURE 20 BONE GROWTH STIMULATORS: SUPPLY CHAIN ANALYSIS
    5.6 PORTER’S FIVE FORCES ANALYSIS
           5.6.1 OVERVIEW
                    TABLE 7 BONE GROWTH STIMULATORS MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.6.2 THREAT OF NEW ENTRANTS
           5.6.3 THREAT OF SUBSTITUTES
           5.6.4 BARGAINING POWER OF SUPPLIERS
           5.6.5 BARGAINING POWER OF BUYERS
           5.6.6 DEGREE OF COMPETITION
    5.7 ECOSYSTEM ANALYSIS
          TABLE 8 BONE GROWTH STIMULATORS: ROLE IN ECOSYSTEM
          FIGURE 21 KEY PLAYERS IN BONE GROWTH STIMULATORS ECOSYSTEM
    5.8 REGULATORY ANALYSIS
           5.8.1 NORTH AMERICA
                    5.8.1.1 US
                                TABLE 9 US FDA: MEDICAL DEVICE CLASSIFICATION
                                TABLE 10 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
                    5.8.1.2 Canada
                                TABLE 11 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
           5.8.2 EUROPE
           5.8.3 ASIA PACIFIC
                    5.8.3.1 Japan
                                TABLE 12 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
                    5.8.3.2 China
                                TABLE 13 CHINA: CLASSIFICATION OF MEDICAL DEVICES
                    5.8.3.3 India
    5.9 PATENT ANALYSIS
           5.9.1 PATENT TRENDS FOR BONE GROWTH STIMULATORS
                    FIGURE 22 PATENT ANALYSIS (JANUARY 2013–SEPTEMBER 2022)
           5.9.2 JURISDICTION AND TOP APPLICANT ANALYSIS
                    FIGURE 23 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR BONE GROWTH STIMULATOR PATENTS, JANUARY 2013–SEPTEMBER 2022
    5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
           5.10.1 REVENUE SHIFT AND REVENUE POCKETS FOR BONE GROWTH STIMULATOR MANUFACTURERS
                     FIGURE 24 REVENUE SHIFT FOR BONE GROWTH STIMULATORS
    5.11 KEY CONFERENCES AND EVENTS IN 2022–2023
            TABLE 14 BONE GROWTH STIMULATORS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
    5.12 TECHNOLOGY ANALYSIS
    5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
           5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BONE GROWTH STIMULATORS
                     TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BONE GROWTH  STIMULATORS (%)
           5.13.2 BUYING CRITERIA
                     FIGURE 26 KEY BUYING CRITERIA FOR END USERS OF BONE GROWTH STIMULATORS
                     TABLE 16 KEY BUYING CRITERIA FOR END USERS OF BONE GROWTH STIMULATORS
    5.14 TRADE ANALYSIS
           5.14.1 TRADE ANALYSIS FOR BONE GROWTH STIMULATORS
                     TABLE 17 IMPORT DATA FOR BONE GROWTH STIMULATORS, BY COUNTRY,  2017–2021 (USD MILLION)
                     TABLE 18 EXPORT DATA FOR BONE GROWTH STIMULATORS, BY COUNTRY,  2017–2021 (USD MILLION)

6 BONE GROWTH STIMULATORS MARKET, BY PRODUCT (Page No. - 78)
    6.1 INTRODUCTION
          TABLE 19 BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
    6.2 BONE GROWTH STIMULATION DEVICES
          TABLE 20 BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 21 BONE GROWTH STIMULATION DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.2.1 EXTERNAL BONE GROWTH STIMULATORS
                    TABLE 22 EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 23 EXTERNAL BONE GROWTH STIMULATORS MARKET, BY REGION,  2020–2027 (USD MILLION)
                    6.2.1.1 Pulsed electromagnetic field devices
                               6.2.1.1.1 Pulsed electromagnetic field devices to witness highest growth in external bone growth stimulators market
                                              TABLE 24 PULSED ELECTROMAGNETIC FIELD DEVICES MARKET, BY REGION,  2020–2027 (USD MILLION)
                    6.2.1.2 Combined magnetic field devices
                               6.2.1.2.1 Combined magnetic field devices portable, battery-powered, and noninvasive
                                              TABLE 25 COMBINED MAGNETIC FIELD DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
                    6.2.1.3 Capacitive coupling devices
                               6.2.1.3.1 Need for frequent battery replacement or recharge—disadvantage associated with CC devices
                                              TABLE 26 CAPACITIVE COUPLING DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
           6.2.2 ULTRASONIC BONE GROWTH STIMULATORS
                    6.2.2.1 Used in treatment of nonunion bone fractures and failed arthrodesis
                                TABLE 27 HCPCS CODE
                                TABLE 28 ULTRASONIC BONE GROWTH STIMULATORS MARKET, BY REGION,  2020–2027 (USD MILLION)
           6.2.3 IMPLANTED BONE GROWTH STIMULATORS
                    6.2.3.1 Implanted bone growth stimulators provide constant stimulation of bone directly at fracture site
                                TABLE 29 IMPLANTED BONE GROWTH STIMULATORS MARKET, BY REGION,  2020–2027 (USD MILLION)
    6.3 BONE MORPHOGENETIC PROTEINS
           6.3.1 SAFE AND EFFECTIVE ALTERNATIVES TO BONE GRAFTS
                    TABLE 30 BONE MORPHOGENETIC PROTEINS MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.4 PLATELET-RICH PLASMA
           6.4.1 ADVANTAGES OF PRP OVER OTHER PRODUCTS USED IN BONE STIMULATION TO DRIVE MARKET
                    TABLE 31 PLATELET-RICH PLASMA MARKET, BY REGION, 2020–2027 (USD MILLION)

7 BONE GROWTH STIMULATORS MARKET, BY APPLICATION (Page No. - 89)
    7.1 INTRODUCTION
          TABLE 32 BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
    7.2 SPINAL FUSION SURGERIES
           7.2.1 SPINAL FUSION SURGERIES TO DOMINATE BONE GROWTH STIMULATORS MARKET
                    TABLE 33 BONE GROWTH STIMULATORS MARKET FOR SPINAL FUSION SURGERIES, BY REGION, 2020–2027 (USD MILLION)
    7.3 DELAYED UNION AND NONUNION BONE FRACTURES
           7.3.1 INCREASING NUMBER OF DELAYED UNION AND NONUNION BONE FRACTURES TO INCREASE DEMAND FOR BONE GROWTH STIMULATORS
                    TABLE 34 BONE GROWTH STIMULATORS MARKET FOR DELAYED UNION AND NONUNION BONE FRACTURES, BY REGION, 2020–2027 (USD MILLION)
    7.4 ORAL AND MAXILLOFACIAL SURGERIES
           7.4.1 BMPS USED IN ORAL AND MAXILLOFACIAL SURGERIES TO FORM BASE FOR DENTAL IMPLANTS
                    TABLE 35 BONE GROWTH STIMULATORS MARKET FOR ORAL AND MAXILLOFACIAL SURGERIES,  BY REGION, 2020–2027 (USD MILLION)
    7.5 OTHER APPLICATIONS
                    TABLE 36 BONE GROWTH STIMULATORS MARKET FOR OTHER APPLICATIONS, BY REGION,  2020–2027 (USD MILLION)

8 BONE GROWTH STIMULATORS MARKET, BY END USER (Page No. - 94)
    8.1 INTRODUCTION
          TABLE 37 BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
    8.2 HOSPITALS AND AMBULATORY SURGERY CENTERS
           8.2.1 LARGEST AND FASTEST-GROWING END USERS OF BONE GROWTH STIMULATORS
                    TABLE 38 BONE GROWTH STIMULATORS MARKET FOR HOSPITALS AND ASCS, BY REGION,  2020–2027 (USD MILLION)
    8.3 HOME CARE SETTINGS
           8.3.1 AVAILABILITY OF REIMBURSEMENT AND INSURANCE COVERAGE TO SUPPORT MARKET GROWTH
                    TABLE 39 BONE GROWTH STIMULATORS MARKET FOR HOME CARE SETTINGS, BY REGION,  2020–2027 (USD MILLION)
    8.4 ACADEMIC AND RESEARCH INSTITUTES
           8.4.1 GROWING RESEARCH ON BONE GROWTH STIMULATION PRODUCTS TO DRIVE MARKET
                    TABLE 40 BONE GROWTH STIMULATORS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES,  BY REGION, 2020–2027 (USD MILLION)

9 BONE GROWTH STIMULATORS MARKET, BY REGION (Page No. - 99)
    9.1 INTRODUCTION
          TABLE 41 BONE GROWTH STIMULATORS MARKET, BY REGION, 2020–2027 (USD MILLION)
    9.2 NORTH AMERICA
          FIGURE 27 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET SNAPSHOT
          TABLE 42 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
          TABLE 43 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
          TABLE 44 NORTH AMERICA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
          TABLE 45 NORTH AMERICA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE,  2020–2027 (USD MILLION)
          TABLE 46 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
          TABLE 47 NORTH AMERICA: BONE GROWTH STIMULATORS MARKET, BY END USER,  2020–2027 (USD MILLION)
           9.2.1 US
                    9.2.1.1 High burden of sports-related injuries to drive market
                                TABLE 48 US: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 49 US: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 50 US: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 51 US: BONE GROWTH STIMULATORS MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                TABLE 52 US: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Market growth driven by rising incidence of bone-related diseases
                                TABLE 53 CANADA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                                TABLE 54 CANADA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 55 CANADA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 56 CANADA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                TABLE 57 CANADA: BONE GROWTH STIMULATORS MARKET, BY END USER,  2020–2027 (USD MILLION)
    9.3 EUROPE
          TABLE 58 EUROPE: BONE GROWTH STIMULATORS MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
          TABLE 59 EUROPE: BONE GROWTH STIMULATORS MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
          TABLE 60 EUROPE: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
          TABLE 61 EUROPE: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE,  2020–2027 (USD MILLION)
          TABLE 62 EUROPE: BONE GROWTH STIMULATORS MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
          TABLE 63 EUROPE: BONE GROWTH STIMULATORS MARKET, BY END USER,  2020–2027 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Largest market for bone growth stimulators in Europe
                                FIGURE 28 GERMANY: POPULATION AGED 65 AND ABOVE, 2015–2021 (MILLION)
                                TABLE 64 GERMANY: BONE GROWTH STIMULATORS MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                                TABLE 65 GERMANY: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 66 GERMANY: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 67 GERMANY: BONE GROWTH STIMULATORS MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                TABLE 68 GERMANY: BONE GROWTH STIMULATORS MARKET, BY END USER,  2020–2027 (USD MILLION)
           9.3.2 UK
                    9.3.2.1 Increasing funding by public and private organizations to drive market
                                TABLE 69 UK: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 70 UK: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 71 UK: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 72 UK: BONE GROWTH STIMULATORS MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                TABLE 73 UK: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Rising prevalence of diabetes to support market growth
                                TABLE 74 FRANCE: BONE GROWTH STIMULATORS MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                                TABLE 75 FRANCE: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 76 FRANCE: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 77 FRANCE: BONE GROWTH STIMULATORS MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                TABLE 78 FRANCE: BONE GROWTH STIMULATORS MARKET, BY END USER,  2020–2027 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Increasing market availability of high-end bone growth stimulators to drive market
                                TABLE 79 ITALY: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 80 ITALY: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 81 ITALY: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 82 ITALY: BONE GROWTH STIMULATORS MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                TABLE 83 ITALY: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
           9.3.5 SPAIN
                    9.3.5.1 Growing geriatric population and subsequent increase in prevalence of target conditions to drive market
                                TABLE 84 SPAIN: BONE GROWTH STIMULATORS MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                                TABLE 85 SPAIN: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 86 SPAIN: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 87 SPAIN: BONE GROWTH STIMULATORS MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                TABLE 88 SPAIN: BONE GROWTH STIMULATORS MARKET, BY END USER,  2020–2027 (USD MILLION)
           9.3.6 REST OF EUROPE
                    TABLE 89 REST OF EUROPE: BONE GROWTH STIMULATORS MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                    TABLE 90 REST OF EUROPE: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
                    TABLE 91 REST OF EUROPE: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                    TABLE 92 REST OF EUROPE: BONE GROWTH STIMULATORS MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                    TABLE 93 REST OF EUROPE: BONE GROWTH STIMULATORS MARKET, BY END USER,  2020–2027 (USD MILLION)
    9.4 ASIA PACIFIC
          FIGURE 29 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET SNAPSHOT
          TABLE 94 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
          TABLE 95 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
          TABLE 96 ASIA PACIFIC: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
          TABLE 97 ASIA PACIFIC: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE,  2020–2027 (USD MILLION)
          TABLE 98 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
          TABLE 99 ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY END USER,  2020–2027 (USD MILLION)
           9.4.1 JAPAN
                    9.4.1.1 Japan dominates Asia Pacific bone growth stimulators market
                                TABLE 100 JAPAN: BONE GROWTH STIMULATORS MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                                TABLE 101 JAPAN: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 102 JAPAN: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 103 JAPAN: BONE GROWTH STIMULATORS MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                TABLE 104 JAPAN: BONE GROWTH STIMULATORS MARKET, BY END USER,  2020–2027 (USD MILLION)
           9.4.2 CHINA
                    9.4.2.1 Expansion in target patient population and modernization of healthcare facilities to drive market
                                TABLE 105 CHINA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                                TABLE 106 CHINA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 107 CHINA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 108 CHINA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                TABLE 109 CHINA: BONE GROWTH STIMULATORS MARKET, BY END USER,  2020–2027 (USD MILLION)
           9.4.3 INDIA
                    9.4.3.1 Growing number of orthopedic surgeries to support market growth
                                TABLE 110 INDIA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 111 INDIA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 112 INDIA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 113 INDIA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                TABLE 114 INDIA: BONE GROWTH STIMULATORS MARKET, BY END USER,  2020–2027 (USD MILLION)
           9.4.4 AUSTRALIA
                    9.4.4.1 Availability of grants for development of advanced treatments to support market growth
                                TABLE 115 AUSTRALIA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                                TABLE 116 AUSTRALIA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 117 AUSTRALIA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 118 AUSTRALIA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                TABLE 119 AUSTRALIA: BONE GROWTH STIMULATORS MARKET, BY END USER,  2020–2027 (USD MILLION)
           9.4.5 SOUTH KOREA
                    9.4.5.1 Supportive government initiatives positively impact market growth
                                TABLE 120 SOUTH KOREA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                                TABLE 121 SOUTH KOREA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 122 SOUTH KOREA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 123 SOUTH KOREA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                TABLE 124 SOUTH KOREA: BONE GROWTH STIMULATORS MARKET, BY END USER,  2020–2027 (USD MILLION)
           9.4.6 REST OF ASIA PACIFIC
                    TABLE 125 GERIATRIC POPULATION, BY COUNTRY, 2015–2021
                    TABLE 126 REST OF ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                    TABLE 127 REST OF ASIA PACIFIC: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
                    TABLE 128 REST OF ASIA PACIFIC: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 129 REST OF ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                    TABLE 130 REST OF ASIA PACIFIC: BONE GROWTH STIMULATORS MARKET, BY END USER, 2020–2027 (USD MILLION)
    9.5 LATIN AMERICA
          TABLE 131 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY COUNTRY,  2020–2027 (USD MILLION)
          TABLE 132 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
          TABLE 133 LATIN AMERICA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
          TABLE 134 LATIN AMERICA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE,  2020–2027 (USD MILLION)
          TABLE 135 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
          TABLE 136 LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY END USER,  2020–2027 (USD MILLION)
           9.5.1 BRAZIL
                    9.5.1.1 Modernization of healthcare facilities to drive market
                                TABLE 137 BRAZIL: BONE GROWTH STIMULATORS MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                                TABLE 138 BRAZIL: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 139 BRAZIL: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 140 BRAZIL: BONE GROWTH STIMULATORS MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                TABLE 141 BRAZIL: BONE GROWTH STIMULATORS MARKET, BY END USER,  2020–2027 (USD MILLION)
           9.5.2 MEXICO
                    9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market
                                TABLE 142 MEXICO: BONE GROWTH STIMULATORS MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                                TABLE 143 MEXICO: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 144 MEXICO: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE,  2020–2027 (USD MILLION)
                                TABLE 145 MEXICO: BONE GROWTH STIMULATORS MARKET, BY APPLICATION,  2020–2027 (USD MILLION)
                                TABLE 146 MEXICO: BONE GROWTH STIMULATORS MARKET, BY END USER,  2020–2027 (USD MILLION)
           9.5.3 REST OF LATIN AMERICA
                    TABLE 147 REST OF LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                    TABLE 148 REST OF LATIN AMERICA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 149 REST OF LATIN AMERICA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 150 REST OF LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 151 REST OF LATIN AMERICA: BONE GROWTH STIMULATORS MARKET, BY END USER,  2020–2027 (USD MILLION)
    9.6 MIDDLE EAST AND AFRICA
           9.6.1 AWARENESS INITIATIVES TO DRIVE ADOPTION OF BONE GROWTH STIMULATORS
                    TABLE 152 MIDDLE EAST AND AFRICA: BONE GROWTH STIMULATORS MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                    TABLE 153 MIDDLE EAST AND AFRICA: BONE GROWTH STIMULATION DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 154 MIDDLE EAST AND AFRICA: EXTERNAL BONE GROWTH STIMULATORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 155 MIDDLE EAST AND AFRICA: BONE GROWTH STIMULATORS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                    TABLE 156 MIDDLE EAST AND AFRICA: BONE GROWTH STIMULATORS MARKET, BY END USER,  2020–2027 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 165)
     10.1 OVERVIEW
     10.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
             TABLE 157 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN BONE GROWTH STIMULATORS MARKET
     10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
             FIGURE 30 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN BONE GROWTH STIMULATORS MARKET
     10.4 MARKET SHARE ANALYSIS
             TABLE 158 BONE GROWTH STIMULATORS MARKET: DEGREE OF COMPETITION
     10.5 COMPETITIVE LEADERSHIP MAPPING
             10.5.1 STARS
             10.5.2 EMERGING LEADERS
             10.5.3 PARTICIPANTS
             10.5.4 PERVASIVE PLAYERS
                        FIGURE 31 BONE GROWTH STIMULATORS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2021
     10.6 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES
             10.6.1 PROGRESSIVE COMPANIES
             10.6.2 STARTING BLOCKS
             10.6.3 RESPONSIVE COMPANIES
             10.6.4 DYNAMIC COMPANIES
                        FIGURE 32 BONE GROWTH STIMULATORS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2021
     10.7 FOOTPRINT ANALYSIS OF TOP PLAYERS IN BONE GROWTH STIMULATORS MARKET
             10.7.1 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN BONE GROWTH STIMULATORS MARKET
                        TABLE 159 PRODUCT FOOTPRINT OF COMPANIES
                        TABLE 160 REGIONAL FOOTPRINT OF COMPANIES
     10.8 COMPETITIVE SCENARIO
             10.8.1 PRODUCT LAUNCHES
                        TABLE 161 KEY PRODUCT LAUNCHES, JANUARY 2019–AUGUST 2022
             10.8.2 DEALS
                        TABLE 162 KEY DEALS, JANUARY 2019–AUGUST 2022
             10.8.3 OTHER DEVELOPMENTS
                        TABLE 163 OTHER KEY DEVELOPMENTS, JANUARY 2019–AUGUST 2022

11 COMPANY PROFILES (Page No. - 176)
     11.1 KEY PLAYERS
(Business overview, Products offered, Recent developments, MnM view, Right to win, Strategic choices made, and Weaknesses and competitive threats)*
             11.1.1 ORTHOFIX MEDICAL INC.
                        TABLE 164 ORTHOFIX MEDICAL INC.: BUSINESS OVERVIEW
                        FIGURE 33 ORTHOFIX, MEDICAL INC.: COMPANY SNAPSHOT (2021)
             11.1.2 DEPUY SYNTHES
                        TABLE 165 DEPUY SYNTHES: BUSINESS OVERVIEW
                        FIGURE 34 DEPUY SYNTHES: COMPANY SNAPSHOT (2021)
             11.1.3 STRYKER
                        TABLE 166 STRYKER: BUSINESS OVERVIEW
                        FIGURE 35 STRYKER: COMPANY SNAPSHOT (2021)
             11.1.4 BIOVENTUS LLC
                        TABLE 167 BIOVENTUS LLC: BUSINESS OVERVIEW
                        FIGURE 36 BIOVENTUS LLC: COMPANY SNAPSHOT (2021)
             11.1.5 MEDTRONIC PLC
                        TABLE 168 MEDTRONIC PLC: BUSINESS OVERVIEW
                        FIGURE 37 MEDTRONIC PLC: COMPANY SNAPSHOT (2021)
             11.1.6 ENOVIS CORPORATION (FORMERLY COLFAX)
                        TABLE 169 ENOVIS CORPORATION (FORMERLY COLFAX): BUSINESS OVERVIEW
                        FIGURE 38 ENOVIS CORPORATION: COMPANY SNAPSHOT (2021)
             11.1.7 ZIMVIE INC. (SUBSIDIARY OF ZIMMER BIOMET)
                        TABLE 170 ZIMVIE INC.: BUSINESS OVERVIEW
                        FIGURE 39 ZIMVIE INC.: COMPANY SNAPSHOT (2021)
             11.1.8 ARTHREX, INC.
                        TABLE 171 ARTHREX, INC.: BUSINESS OVERVIEW
             11.1.9 TERUMO CORPORATION
                        TABLE 172 TERUMO CORPORATION: BUSINESS OVERVIEW
                        FIGURE 40 TERUMO CORPORATION: COMPANY SNAPSHOT (2021)
             11.1.10 OSSATEC BENELUX LTD.
                        TABLE 173 OSSATEC BENELUX LTD.: BUSINESS OVERVIEW
             11.1.11 ISTO BIOLOGICS
                        TABLE 174 ISTO BIOLOGICS: BUSINESS OVERVIEW
             11.1.12 EMBER THERAPEUTICS, INC.
                        TABLE 175 EMBER THERAPEUTICS, INC.: BUSINESS OVERVIEW
             11.1.13 REGEN LAB SA
                        TABLE 176 REGEN LAB SA: BUSINESS OVERVIEW
             11.1.14 ALTIS BIOLOGICS (PTY) LTD.
                        TABLE 177 ALTIS BIOLOGICS (PTY) LTD.: BUSINESS OVERVIEW
             11.1.15 ITO CO., LTD.
                        TABLE 178 ITO CO., LTD.: BUSINESS OVERVIEW
     11.2 OTHER COMPANIES
             11.2.1 ELIZUR CORPORATION
             11.2.2 BTT HEALTH GMBH
             11.2.3 STIMULATE HEALTH
             11.2.4 VQ ORTHOCARE
             11.2.5 KINEX MEDICAL COMPANY, LLC

*Details on Business overview, Products offered, Recent developments, MnM view, Right to win, Strategic choices made, and Weaknesses and competitive threats might not be captured in case of unlisted companies.

12 APPENDIX (Page No. - 210)
     12.1 DISCUSSION GUIDE
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL
     12.3 CUSTOMIZATION OPTIONS
     12.4 RELATED REPORTS
     12.5 AUTHOR DETAILS

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the bone growth stimulators market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Extensive primary research was conducted after acquiring knowledge about the bone growth stimulators market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such hospitals, ambulatory surgery centers (ASCs), home care settings, and academic & research institutes) and supply side (such as product manufacturers, wholesalers, channel partners, and distributors). Approximately 32% of the primary interviews were conducted with stakeholders from the demand side while those from the supply side accounted for the remaining 48%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

A breakdown of the primary respondents is provided below:

Bone Growth Stimulator Market Size, and Share

*Others includes sales managers, marketing managers, business development managers, product managers, distributors, and suppliers

Note: Tiers are defined based on a company’s total revenue. As of 2021: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

All major product manufacturers offering various bone growth stimulators were identified at the global/regional level. Revenue mapping was done for the major players (who contribute at least 35-40% of the overall market share at the global level) and was extrapolated to arrive at the global market value of each type segment. The market value of bone growth stimulators was also split into various segments and subsegments at the region and country level based on:

  • Product mapping of various manufacturers for each type of bone growth stimulators at the regional and country-level 
  • Relative adoption pattern of each bone growth stimulators among key application segments at the regional and/or country-level 
  • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country-level 
  • Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level 

Bone Growth Stimulator Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the bone growth stimulators industry.

Report Objectives

  • To define, describe, and forecast the bone growth stimulators market based on the product, type, application, and region
  • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze micro markets with respect to their growth trends, prospects, and contributions to the total market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the revenue of market segments with respect to five regions, namely, North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and RoLA), and the Middle East & Africa
  • To strategically profile the key players and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments such as collaborations, partnerships, acquisitions, expansions, and product launches in the bone growth stimulators  market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global bone growth stimulators market report:

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)/
Report Code
MD 5234
Published ON
Oct, 2022
REQUEST FREE SAMPLE REPORT
Choose License Type
BUY NOW
Inquire Before Buying
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Bone Growth Stimulator Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2023 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback